Source: UNIV OF WISCONSIN submitted to NRP
MYCOTOXINS IN A CHANGING WORLD
Sponsoring Institution
National Institute of Food and Agriculture
Project Status
COMPLETE
Funding Source
Reporting Frequency
Annual
Accession No.
1024598
Grant No.
(N/A)
Cumulative Award Amt.
(N/A)
Proposal No.
(N/A)
Multistate No.
NC-1183
Project Start Date
Oct 1, 2020
Project End Date
Sep 30, 2021
Grant Year
(N/A)
Program Code
[(N/A)]- (N/A)
Recipient Organization
UNIV OF WISCONSIN
21 N PARK ST STE 6401
MADISON,WI 53715-1218
Performing Department
Bacteriology
Non Technical Summary
Mycotoxin contamination by toxin producing fungi is a continuing problem in Wisconsin (and the Midwest in general) resulting in both monetary loss (crop destruction) and health concerns (animal feeds). The most common fungi that produce mycotoxins in our food and feed products belong to the genera Aspergillus and Fusarium. The United States screens food well enough that we do not get high mycotoxin concentrations in human food (although this is costly), but occasional deadly mycotoxin poisonings have been attributed in pet foods (particularly aflatoxin contamination of dog food) which are not screened as tightly products intended for human consumption. These problems have been exacerbated in recent years with the finding that mycotoxins are concentrated in the dried distillers grains, the products accumulated from using maize as an ethanol source, and the increasing occurrence of mycotoxins thought to be due to changes in the climate. In fact, the climate changes affecting the world are expected to increase the frequency and concentration of mycotoxin contamination of crops with estimates of loss to a single crop (corn) from a single mycotoxin (aflatoxin) from $52.1 million to $1.68 billion annually in the United States alone. This continuation project will focus on (i) studies aimed at identifying conserved genes and molecules which may be amenable for targeting for controling fungal growth and/or mycotoxin synthesis and (ii) exploring the hypothesis that mycotoxin synthesis is impacted by the microbiome. Methodologies used to carry out these aims include genetic studies (where target genes/molecules can be removed or overexpressed in fungi to assess their impact on mycotoxin production and/or fungal development), pathogenicity studies on the host to examine mycotoxin synthesis and virulence in vivo and through fungal-bacterial co-culture in vitro and in vivo to assess impacts of the microbiome on mycotoxin production.
Animal Health Component
(N/A)
Research Effort Categories
Basic
100%
Applied
(N/A)
Developmental
(N/A)
Classification

Knowledge Area (KA)Subject of Investigation (SOI)Field of Science (FOS)Percent
7121830110230%
7121510110235%
7121549104035%
Goals / Objectives
Objective 3: Increase understanding of internal and external factors related to the biology and ecology of mycotoxigenic fungi that determine mycotoxin production potential and outcomes. a) Identify fungal genetic factors determining mycotoxin production including evaluation of epigenetic factors, genes outside of the mycotoxin biosynthetic gene clusters, and using multiple fungal genotypes. b) Assess the role of abiotic factors such as water activity and temperature on mycotoxin production. c) Evaluate the role of microbe-microbe interactions, and host microbiome context on mycotoxin production.
Project Methods
Aim 1: Conserved cellular mechanisms regulating mycotoxin synthesis, virulence or fungal development. Specific goals: to understand how LaeA regulates the Ham sensor complex MAPK pathway in A. flavus and if this pathway impacts fungal development, aflatoxin production and virulence. We hypothesize that ham mutants will be impaired in virulence due to inability of hyphae to fuse and penetrate seed tissue properly. We have already identified the five ham genes associated with this complex and deleted them in A. flavus. This project is a continution of Hatch Multistate 1012878, so this objective was completed last year. We have gained tremendous insight into the role of fungal:bacterial communities on mycotoxin synthesis. We find that when bacteria and fungi encounter each other, mycotoxin synthesis by fungi can either be induced (putative protection for fungus) or repressed (putative advantage for bacterium). This has now changed our concept of mycotoxin production in crops. We have published some of this work (Frontiers Microbiology. 10:403. doi: 10.3389/fmicb.2019.00403.). Previous work showed that, moreover, bacteria can enter inside of pathogenic fungi, a topic we are further exploring. Furthermore, we find that fungal toxins can impede growth of pathogenic bacteria.Aim 2. Impacts of the microbiome on mycotoxigenic fungi. Specific goals: to elucidate R. solanacearum/fungal interactions and impacts on mycotoxin production and fungal virulence and survival. We hypothesize that mycotoxin production increases in fungi when confronted with bacteria as part of a general stress response.A). Bikaverin: As mentioned above, we have found that bikaverin is induced in Fusarium spp. during confrontations with R. solanacearum (data not shown). This induction is apparently in response to ralsolamycin as bikaverin is not induced when Fusarium is grown next to the DrmyA R. solanacearum mutant. We will confirm this by co-culturing WT and DrmyA R. solanacearum strains with several Fusarium spp. and measuring bikaverin production and bikaverin gene expression. We also will culture Fusarium spp. with purified ralsolamycin. We expect more bikaverin synthesis in confrontations with WT R. solanacearum. If this is the case, we will delete the bikaverin synthase in one Fusarium spp. (Dbik) and then ask if loss of bikaverin production changes R. solanacearum/Fusarium interactions. For instance, it may be that bikaverin protects the fungus from colonization of chlamydospores by R. solanacearum.We are also interested to examine how polymicrobial virulence may be affected by both bikaverin and ralsolamycin. For this aspect, we will focus on F. oxysporum as, like R. solanacearum it is a wilt pathogen and we can assess both microbes for virulence in tomato plants. Currently we have GFP WT strains of both R. solanacearum and F. oxysporum to aid in visualization of microbial interactions in planta. One goal is to see if chlamydospores are formed in plant tissue and, if so, are they colonized by Ralstonia. We will examine both WT isolates of both microbes as well as DrmyA and Dbik strains as appropriate. We will also examine if bikaverin production increases in polymicrobial disease.B) Imizoquin: In an opposite manner to how ralsolamycin induces bikaverin in Fusarium spp., we have identified a novel A. flavus secondary metabolite we call imizoquin (data not shown) that is suppressed by ralsolamycin. Currently, we have no data on the role - if any - of imizoquin on A. flavus or R. solanacearum. We have identified the imizoquin gene cluster in A. flavus and have made both a deletion and overexpression mutant (data not shown). We will now ask if these mutants impact R. solanacearum colonization of A. flavus and if the mutants are altered in any manner such as in fungal growth, spore production, aflatoxin synthesis and/or virulence.

Progress 10/01/20 to 09/30/21

Outputs
Target Audience:The target audience is the general research community including NC members and participants at the Asilomar Fungal Genetics and American Phytopathological Society meetings. Changes/Problems: Nothing Reported What opportunities for training and professional development has the project provided?This was the second year of the COVID-19 pandemic, which still precluded travel to meetings. Still, all of my students presented their work at a local meeting in person. Also, my student Nandhitha Venkatesh graduated in August 2021 and has started a job with industry, Mycoworks. How have the results been disseminated to communities of interest?We submitted three manuscripts last year and all are now accepted What do you plan to do during the next reporting period to accomplish the goals? Nothing Reported

Impacts
What was accomplished under these goals? We have had major advances in our work with the publication/acceptance of three manuscripts. We have focused on the interaction of the wilt bacteriums Ralstonia solanacearum with mycotoxigenic fungi. In a paper published in Microorganisms, we explored the consequences of mixed infection in tomato disease by the wilt pathogens R. solanacearum and Fusarium oxysporum f. sp. lycopersici. Although both pathogens occupy the xylem, the costs of mixed infections on wilt disease are unknown. Our results demonstrate that bacterial wilt severity is reduced in co-infections, that synthesis of the mycotoxin bikaverin by Fusarium contributes to bacterial wilt reduction and that the arrival time of each microbe at the infection court is important in driving severity of wilt disease. Further, analysis of the co-infection root secretome identified previously uncharacterized secreted metabolites that reduce R. solanacearum growth in vitro and provide protection to tomato seedlings against bacterial wilt disease. Taken together, these results highlight the need to understand the consequences of mixed infections in plant disease. In a manuscript published in Current Biology, we examined the hypothesis that specialized fungal survival structures, chlamydospores, induced by bacterial lipopeptides serve as bacterial reservoirs. We find that symbiotic and pathogenic gram-negative bacteria from non-endosymbiotic taxa enter and propagate in chlamydospores. Internalized bacteria have higher fitness than planktonic bacteria when challenged with abiotic stress. Further, tri-cultures ofRalstonia solanacearum, Pseudomonas aeruginosa,and Aspergillus flavus reveal the unprecedented finding that chlamydospores are colonized by endofungal bacterial communities. Our work identifies a previously unknown ecological role of chlamydospores, provides an expanded view of microbial niches, and presents significant implications forthe persistence of pathogenic and beneficial bacteria.

Publications

  • Type: Journal Articles Status: Accepted Year Published: 2022 Citation: Eagan JL, Steffan BN, Ortiz SC, Drott M, Goldman GH, Hull CM, Keller NP and Bastos RW. (2022) Inadvertent selection of a pathogenic fungus highlights areas of concern in human clinical practices. J. Fungi. 8(2), 157; https://doi.org/10.3390/jof8020157
  • Type: Journal Articles Status: Accepted Year Published: 2022 Citation: Venkatesh N, Greco C, Drott MT, Koss MJ, Ludwikoski L, Keller NM, Keller NP (2022) Bacterial hitchhikers derive benefits from fungal housing. Current Biol. Accepted
  • Type: Journal Articles Status: Published Year Published: 2021 Citation: Venkatesh N, Koss MJ, Greco C, Nickles G, Wiemann P, Keller NP (2021) Secreted secondary metabolites reduce bacterial wilt severity of tomato in bacterial-fungal co-infections. Microorganisms 9(10):2123. doi: 10.3390/microorganisms9102123.